• Return to Headlines

Jazz Pharmaceuticals Shares Up 32.6% Since SmarTrend's Buy Recommendation (JAZZ)

By Nick Russo

SmarTrend identified an Uptrend for Jazz Pharmaceuticals (NASDAQ:JAZZ) on December 23rd, 2016 at $108.62. In approximately 3 months, Jazz Pharmaceuticals has returned 32.65% as of today's recent price of $144.08.

In the past 52 weeks, Jazz Pharmaceuticals share prices have been bracketed by a low of $95.80 and a high of $194.73 and are now at $144.08, 50% above that low price. The 200-day and 50-day moving averages have moved 0.47% lower and 1.61% higher over the past week, respectively.

Jazz Pharmaceuticals, Inc. develops and markets treatments for neurological and psychiatric conditions. The Company produces treatments for cataplexy, excessive daytime sleepiness, and ethylene glycol and methanol poisoning in humans.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Jazz Pharmaceuticals shares.

Log in and add Jazz Pharmaceuticals (JAZZ) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights jazz pharmaceuticals

Ticker(s): JAZZ